secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENDRA Life Sciences Inc. (NDRA)
CIK:        0001681682
Form:       8-K/A
Filed at:   2025-10-15T23:59:59+00:00
Accession:  0001654954-25-011825
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 1.02, 3.02, 5.08, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ENDRA raises $4.9M in private placement to launch digital asset treasury strategy
--------------------------------------------------------------------------------

- Sold 744,340 shares/pre-funded warrants plus up to 1,488,680 common warrants at $6.57 per unit; $6.81 for director participant.
- Gross proceeds ~$4.9M; up to $14.4M if common warrants exercised; majority allocated to digital asset treasury (DAT) strategy.
- Engaged Arca Investment Management to manage $3.5M of DAT assets; fees 1.25–1.75% AUM + 10–15% performance fee; issued 400,000 advisory warrants.
- Terminated at-the-market equity facility with Ascendiant effective October 13, 2025.
- 2025 annual meeting set for December 9, 2025; record date October 16, 2025; stockholder proposal deadline October 27, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1681682/000165495425011825/0001654954-25-011825-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1681682/000165495425011825/endra_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001654954-25-011825

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer